FIELD: medicine.
SUBSTANCE: invention relates to inhalation therapy combined with electronic monitoring devices. Disclosed is a method of treating cardiac arrhythmia in a subject, comprising: identifying cardiac arrhythmia in a subject using an electronic monitoring device, which is worn by the subject; aerosol spraying of a pharmaceutical composition in less than 9 minutes using an inhaler, wherein the pharmaceutical composition contains a therapeutically effective amount of at least one antiarrhythmic agent or a pharmaceutically acceptable salt thereof; administering an aerosol pharmaceutical composition to a subject, thereby treating cardiac arrhythmia.
EFFECT: invention provides treatment of subject within 90 minutes from the moment of onset of cardiac arrhythmia.
56 cl, 11 dwg, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
ALPHA-1 PROTEINASE INHIBITOR FOR DELAY OF BEGINNING OR PROGRESS OF PULMONARY EXACERBATIONS | 2012 |
|
RU2635482C2 |
RAPAMYCIN-CONTAINING COMPOSITION ADMINISTERED BY INHALATION FOR TREATING AGE-RELATED DISEASES | 2015 |
|
RU2718583C2 |
INHALATION DOSAGE FORM OF RAPAMYCIN FOR TREATING PULMONARY HYPERTENSION | 2015 |
|
RU2732908C2 |
DRUG COMBINATION | 2014 |
|
RU2666624C2 |
COMBINATION AND PHARMACEUTICAL PREPARATION FOR TREATING INFLAMMATORY AND OBSTRUCTIVE RESPIRATORY DISEASES | 2005 |
|
RU2438660C2 |
RAPAMYCIN FOR TREATING LYMPHANGIOLEIOMYOMATOSIS | 2014 |
|
RU2707285C2 |
DIRECTED DELIVERY OF SPRAY-DRIED COMPOSITIONS INTO THE LUNGS | 2016 |
|
RU2731212C2 |
INTRODUCTION OF ILOPROST IN FORM OF AEROSOL BOLUSES | 2012 |
|
RU2605849C2 |
INHALATION COMPOSITIONS CONTAINING MONTELEUKAST ACID AND PDE-4 INHIBITOR OR INHALATION CORTICOSTEROID | 2008 |
|
RU2470639C2 |
AEROSOL FLUOROCHINOLONES AND THEIR APPLICATIONS | 2006 |
|
RU2428986C2 |
Authors
Dates
2022-03-24—Published
2017-02-01—Filed